News room
Technophage once again classified as ‘PME líder’
Technophage has been awarded by IAPMEI (Agency for Competitiveness and Innovation) with the distinction of 'PME líder'. This certification...
TechnoPhage announces U.S. FDA clearance of IND application to initiate clinical trial
U.S. FDA has just cleared the IND application of bacteriophage cocktail TP-102 to initiate Phase I/IIa clinical trial. TP-102 is a cocktail of five...
Technophage among companies with higher investment in R&D
In 2019, Technophage was among the top 100 companies with the highest R&D investment in Portugal. According to the provisional results of...
TechnoPhage is certified for GMP production of biological medicines
TechnoPhage owns an innovative unit for the production of biological medicines that has now obtained authorization from INFARMED for the manufacture...
COVID-19 New Challenge: joint effort to mitigate world’s pandemic crisis
COVID-19 New Challenge: joint effort to mitigate world’s pandemic crisis (TechnoPhage S.A., Faculty of Pharmacy of University of Lisbon and Vector...